Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes | Zendy

Marco Valgimigli | Zendy; Enrico Frigoli | Zendy; Sergio Leonardi | Zendy; Martina Rothenbühler | Zendy; Andrea Gagnor | Zendy; Paolo Calabró | Zendy; Stefano Garducci | Zendy; Paolo Rubartelli | Zendy; Carlo Briguori | Zendy; Giuseppe Andò | Zendy; Alessandra Repetto | Zendy; Ugo Limbruno | Zendy; Roberto Garbo | Zendy; Paolo Sganzerla | Zendy; Filippo Russo | Zendy; Alessandro Lupi | Zendy; Bernardo Cortese | Zendy; Arturo Ausiello | Zendy; Salvatore Ierna | Zendy; Giovanni Esposito | Zendy; Patrizia Presbitero | Zendy; Andrea Santarelli | Zendy; Gennaro Sardella | Zendy; Ferdinando Varbella | Zendy; Simone Tresoldi | Zendy; Nicoletta De Cesare | Zendy; Stefano Rigattieri | Zendy; Antonio Zingarelli | Zendy; Paolo Tosi | Zendy; Arnoud W.J. van ‘t Hof | Zendy; Giacomo Boccuzzi | Zendy; Elmir Ömerovic | Zendy; Manel Sabaté | Zendy; Dik Heg | Zendy; Peter Jüni | Zendy; Pascal Vranckx | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

Author(s) -

Marco Valgimigli,

Enrico Frigoli,

Sergio Leonardi,

Martina Rothenbühler,

Andrea Gagnor,

Paolo Calabró,

Stefano Garducci,

Paolo Rubartelli,

Carlo Briguori,

Giuseppe Andò,

Alessandra Repetto,

Ugo Limbruno,

Roberto Garbo,

Paolo Sganzerla,

Filippo Russo,

Alessandro Lupi,

Bernardo Cortese,

Arturo Ausiello,

Salvatore Ierna,

Giovanni Esposito,

Patrizia Presbitero,

Andrea Santarelli,

Gennaro Sardella,

Ferdinando Varbella,

Simone Tresoldi,

Nicoletta De Cesare,

Stefano Rigattieri,

Antonio Zingarelli,

Paolo Tosi,

Arnoud W.J. van ‘t Hof,

Giacomo Boccuzzi,

Elmir Ömerovic,

Manel Sabaté,

Dik Heg,

Peter Jüni,

Pascal Vranckx

Publication year - 2015

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1507854

Subject(s) - bivalirudin , medicine , conventional pci , percutaneous coronary intervention , cardiology , myocardial infarction , adverse effect , acute coronary syndrome , heparin , stroke (engine) , revascularization , mechanical engineering , engineering

Conflicting evidence exists on the efficacy and safety of bivalirudin administered as part of percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research